GE HealthCare Technologies (GEHC) Depreciation & Amortization (CF) (2022 - 2026)

GE HealthCare Technologies has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $78.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 18.18% year-over-year to $78.0 million; the trailing twelve-month figure through Mar 2026 stood at $299.0 million (up 12.41% YoY), and the FY2025 full-year result was $287.0 million, up 7.09% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $78.0 million, up from $74.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $78.0 million in Q1 2026, with the low at $56.0 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $65.2 million across 5 years, with a median of $65.0 million in 2024.
• Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) decreased 2.94% — and 2026, when it gained 18.18%.
• GE HealthCare Technologies' Depreciation & Amortization (CF) stood at $59.0 million in 2022, then advanced by 1.69% to $60.0 million in 2023, then climbed by 8.33% to $65.0 million in 2024, then grew by 13.85% to $74.0 million in 2025, then rose by 5.41% to $78.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $78.0 million (Q1 2026), $74.0 million (Q4 2025), and $75.0 million (Q3 2025), per Business Quant data.